According to the National Osteoporosis Foundation, about 10 million Americans have osteoporosis and another 44 million have low bone density which places them at risk of developing osteoporosis. As Baby Boomers age, that number is expected to climb as 10,000 people turning 65 every day. In this interview, bone health expert John Neustadt, ND, explains why bone density scan is not the most clinically important endpoint and how to identify fracture risk in clinical practice. Neustadt details his whole-person approach to reducing fracture risk that includes medications, diet, lifestyle, environmental, and dietary supplements.
About the Author
John Neustadt, ND, received his naturopathic doctorate from Bastyr University. He was founder and medical director of Montana Integrative Medicine and founder and president of Nutritional Biochemistry, Inc. (NBI) and NBI Pharmaceuticals. Neustadt is a medical expert for TAP Integrative, a nonprofit organization educating doctors about integrative medicine. He has published more than 100 research reviews and was recognized by Elsevier as a Top Ten Cited Author for his work. Neustadt’s continuing-education podcast on Insomnia: An Integrative Approach is available for free through the Natural Medicine Journal.
About the Sponsor
NBI was started by John Neustadt, ND, in 2006 when he couldn’t find formulas he needed for his patients. NBI’s clinically validated products unlock people’s full health potential. NBI products solve 2 problems he was having. Existing products didn’t contain the dose or combination of nutrients used in clinical trials and shown to work. Equally frustrating, other companies would cite studies on their websites, but then use lower amounts of nutrients than what was used in the study or use entirely different nutrients that weren’t supported by the research. Neustadt’s approach to formulating product is based on more than 2 decades of clinical research, clinical work with patients and has published more than 100 research reviews and 3 books and was recognized by Elsevier as a Top Ten Cited Author in the world for his work.
NBI’s Osteo-K and Osteo-K Minis deliver the clinical dose of nutrients shown in more than 25 clinical trials to grow stronger bones and reduce fractures more than 80 percent.
NBI is and always has been a family-owned company. We don’t manufacture anything we wouldn’t take ourselves or give to our own family. No matter what we do, our promise to physicians using our products is to help their patients, and to customers purchasing directly from NBI, is uncompromising quality.
NBI is a name you can trust. But don’t take our word for it. Spend some time on our website, learn about our products, and educate yourself on the hundreds of research citations and studies that they’re based on.
Use coupon NMJOSTEOK and save 10% off your next purchase of Osteo-K or Osteo-K Minis. Coupon code is valid through December 31, 2020 for one use per customer. Coupon code has no cash value and may not be combined with any other discount code.
In this interview Heather Zwickey, PhD, provides an important update about Covid-19 for healthcare professionals. She discusses the concerning fact that people can be asymptomatic for a longer period of time than previously expected and that the viral shedding may take longer as well. She also discusses the connection between pollen allergies and Covid-19, as well as GI symptoms, conjunctivitis, and supporting the gut microbiome. Zwickey is executive program chair and a professor at National University of Natural Medicine in Portland, OR, and also has previous training and experience with infectious diseases.
About the Expert
Heather Zwickey, PhD, earned a PhD in Immunology and Microbiology from the University of Colorado Health Sciences Center with a focus on infectious disease. Zwickey went on to complete a postdoctoral fellowship and teach medical school at Yale University. At the National University of Natural Medicine in Portland, OR, Zwickey launched the Helfgott Research Institute and established the School of Graduate Studies, developing programs in research, nutrition, and global health, among others. She currently leads an NIH funded clinical research training program. She teaches at many universities and speaks at conferences worldwide. At Helfgott Research Institute, Zwickey applies her immunology expertise to natural medicine, with specific interest in the gut-brain axis in neuroinflammation.
Transcript
Karolyn Gazella: There is no question that the Covid-19 crisis continues to be a rapidly moving target. Hello, I'm Karolyn Gazella, your host and the publisher of the Natural Medicine Journal, an online peer-reviewed journal for integrative healthcare professionals. Yes, things are moving fast when it comes to Covid-19, but we at the Natural Medicine Journal remain committed to keeping abreast as best we can. Today we're going to be tackling the ever-changing picture of Covid-19 symptoms, as well as new research on pollen counts and Covid-19 and protecting the gut microbiome. My go to expert on this topic continues to be highly respected integrative health researcher and immunologist, Dr Heather Zwickey. If this is your first time listening to Dr Zwickey, she is executive program chair and a professor at National University of Natural Medicine in Portland, Oregon. Dr Zwickey also has previous training and experience with infectious diseases. Dr Zwickey, thank you once again for joining me to talk about this very complex topic.
Heather Zwickey, PhD: Thanks for having me.
Gazella: So let's start by having you give us an update since we last spoke 2 weeks ago. Anything new from your perspective?
Zwickey: Yes, there's a couple of things that are coming out I think that are worth noting for physicians. First, as we're finally hearing, young people also get this virus. They may not die, but many are being hospitalized. And I think as we talked about last time we chatted, the average age was 44 in China, it was not in the 80s. So keep in mind that younger people are still susceptible. And I think one of the biggest updates is the time of exposure to symptoms. We originally thought it was 2 to 3 days, but now we're seeing that it can be anywhere from 2 to 11 days. That's a huge time span. And we don't know why. It could be the number of viral particles that people are exposed to, or it could be various health factors related to the health of the patient. We just don't know. But during that entire time span, people could be asymptomatic and yet be shedding virus.
Gazella: Yeah. That is really important. And it's a good reminder as to why we're focusing on social distancing so aggressively right now. So that's great. And I do want to talk about the symptom profile, but first I want to discuss a brand new study that just came out in the journal Allergy that looked at pollen counts and Covid-19. Now obviously this can affect a lot of patients this time of year who are dealing with allergies. So what's the connection and what should practitioners consider telling their allergy patients about this new information?
Zwickey: So few things to think about with respect to this. The first thing is that people start worrying when they start having symptoms of allergies because many of the symptoms are shared with upper respiratory viral infections. So the stress isn't good. Secondly, we already know that there's a shortage of tests, and if people start worrying that their allergies are Covid-19 they're going to start using tests that we actually need for people who have Covid-19. So that's not good. But from an immunological perspective, the way that we think about this is allergies are a TH2 response. So when you start mounting an allergy response to birch, or ragweed, or any sort of pollen, you need a TH2 response for the allergy response. But what you need to fight the infection is a TH1 response, not TH2.
In some respiratory infections we're seeing that allergies are reducing the proinflammatory response, including the type 1 and type 3 interferons, and that's usually what we see starting to launch the anti-infection response. So if you have allergies, specifically allergies to birch pollen is what was reported in the journal Allergy, you may have less type 1 and type 3 interferons and mount less of an immune response to any upper respiratory infection. So the data that they used actually came from rhinovirus. We don't know exactly what allergies are going to do to a SARS-CoV-2 infection. In young people it could actually minimize their symptoms even more, even though they're infectious. And in older people and higher-risk populations, people who have comorbidities, it could reduce their ability to fight an infection.
Gazella: That's fascinating. Is there any advice that we should be giving patients who have allergies during this crisis?
Zwickey: Yeah, it's interesting. If you just get online and you Google allergies versus Covid-19, one of the things you'll find are symptom comparisons. So if you have allergies, you're probably not going to have a fever. That's the biggest thing. And if you don't have a fever, it's more likely the allergy and not the Covid-19. If you have a fever, then I would start thinking, well, this could be something different. And then if you get the cough that goes with the fever, now is when you start thinking, well, this could be Covid-19. So just get online and look at those symptom pictures and see where you're at. A headache is not a sign of Covid-19, a headache alone. But a headache, a sinus headache especially, may come with your allergies.
Gazella: That's great advice. Should people with allergies stay indoors more on windy days, or is there any lifestyle-based advice?
Zwickey: It's all the same things we've been telling people with allergies for a long time. Yes, you should stay indoor on windy days, you shouldn't open your car windows. Or if you're driving, put the air on recirculate instead of fresh air so that you're not exposed to more and more of that pollen. The other thing you may consider is using a local honey, which usually contains pollen. And we know if you eat the allergen you are less likely to have that TH2 response to it. So, all of those things are true in these cases.
Gazella: Great. Great advice. So let's dig a little bit more deeply into the topic of symptoms. Now, I have to say, I've been fascinated by the fact that Covid-19 has a growing list of really diverse symptoms, in addition to the typical fever and dry cough that you mentioned. For example, I've been reading articles that GI issues can be a symptom. Now, while it's not a primary symptom, patients with a fever and GI issues may have Covid-19. What's this connection all about?
Zwickey: So the same ACE-2 receptors that we've already talked about that are in the lungs and the kidneys are also in the gut. So if you happen to swallow the virus instead of breathe it, it'll infect the gut instead of the lungs. And when you mount an immune response, one of the cytokines that's made in the gut is TNF alpha, and we know that TNF alpha alone can cause diarrhea. Importantly, many people who have GI symptoms can also be shedding virus in stool. And that brings up something else I wanted to mention, the data from the Chinese that are coming out right now are showing that viral shedding is 20 days. It's not 2 weeks, it's 3 weeks.
So think about the fact that we've had people in quarantine for 2 weeks and then we let them go, and they can actually be shedding for another full week. In fact, Chinese scientists said that some patients actually shed up to 37 days. So that's why there's a continued focus on physical distancing. And I'm trying to change the vernacular from social distancing to physical distancing because people need to be social. It's such a good coping skill and I really hope people are communicating with their friends and family.
Gazella: That is a great point. Physical distancing. I'm going to make sure to use that in the future as well. Now, another symptom that's been discussed in mainstream media is pink eye or red eyes. Now this totally makes sense because people touch their eyes pretty frequently, and if they have the virus on their hands, they can infect the eyes. What do we need to know about this symptom when it comes to Covid-19?
Zwickey: So first of all, it's true. There is a conjunctivitis that can be associated with Covid-19, although it's relatively rare. Data coming out of China and Italy suggest it's about 1 in 1,000 will develop conjunctivitis. So the first thing remember as a doc is to treat these patients as Covid-19 patients. They are infectious, they're shedding virus. And a lot of times when we see the red eye we think that it's limited to the eye. It's not. Also remember that this isn't bacterial, so the antibacterial drops that you drop in people's eyes aren't going to work. You're to treat this like you would treat any other Covid-19 infection, and it can be severe. People can develop a lot of inflammation in their eye from this particular virus. So treating inflammation the way you would as a physician is the way to go.
Gazella: Okay, great advice. Now, is it common for a virus to expand its symptom profile like this? Does this tell us anything about the severity or the uniqueness of this particular virus?
Zwickey: Well, it's not so much an expansion of symptoms. These symptoms have been happening all along, they were just happening in much lower numbers, which meant that doctors didn't know if they were unique to individuals or part of the SARS-CoV-2 infection. So until the numbers became really high we weren't seeing them in high enough numbers to report them. So this is kind of a lesson in epidemiology. If there's low numbers, they could be random. When the numbers get higher, now we can form correlations. Now there's another piece of this. Viruses can infect any tissue for which there is a receptor, and for SARS-CoV-2 the receptor, ACE-2, is distributed among many different tissues. And because the receptor's widespread, there's widespread symptoms. We call this tissue tropism, that the virus is attracted to the tissues that express the receptor. Another virus that does stuff like this is measles. Measles binds to 3 different receptors in 3 different tissues, and as a result you see measles in the lungs and the gut, and in immune cells as well. So, it's true for other viruses, it's just that until you get the law of large numbers, we don't see the symptoms appear in high enough quantity to associate it with this particular infection.
Gazella: Okay, great. That was a great explanation. So I want to end our conversation with the gut microbiome, kind of going back to our conversation about GI symptoms. Now, there's a significant connection between the gut, the immune system, and our ability to fight viruses. What steps can we take to help protect and enhance the gut microbiome?
Zwickey: Yeah, this is so true. We know that if you disrupt the gut microbiome, you make anyone, animal, human or insect susceptible to infections. So the A number 1 thing you can do for the microbiome, of course, is eat vegetables, especially vegetables with good prebiotic fibers. I'm thinking onions, Jerusalem artichoke, sunchokes, leeks, garlic. Potatoes are a vegetable, but they're not the best for feeding the microbiome. Although I'd much rather have you eat a potato than a cookie, but I'd rather have you eat asparagus or greens than a potato. The other thing that most of us forget get is spices are prebiotic. So cooking with spices, rosemary, thyme, basil, oregano, cinnamon, all of those things are going to help feed the bacteria in your gut, your gut microbiome. The next thing that many people would think of is probiotics, and I go probiotic first with food. So thinking about keifer, kombucha, sauerkraut, and yogurt. And usually people are going to gravitate towards the yogurt because they like the sweet taste, but remember the sugar isn't good. So if you're going to go for yogurt, you're going to go for the low-sugar versions.
And then probiotic supplements, of course, could be helping the gut for some people. And while it's true that we have shown that probiotics can improve gut health, we don't actually know which probiotics work best with each individual. And remember, each person's microbiome is different, we all have our own ecosystem. So it'll be great when we can individualize them, but in the meantime, I would consider it self-experimentation, that if you're going to try a probiotic and you haven't ever tried one before, if it doesn't make you feel good, stop. That's not your combo and try something different. What you're doing with your gut is you're regulating both your immune system and your nervous system. So 80% of your immune system is in your gut and more than that for your nervous system. In fact, the microbes in your gut are responsible for making much of the serotonin in your body, and serotonin is contributing to your immune response. So, keep in mind that if your gut's not healthy, then even if every aspect of you feels healthy, you're not healthy.
Gazella: Great, great points. Well, once again, Dr Zwickey, this has been very informational. Thank you so much for joining me and keeping us abreast of the various complexities associated with Covid-19. Thank you so much.
Zwickey: You're welcome.
Gazella: So this podcast is brought to you by Natural Medicine Journal. You can find more information at naturalmedicinejournal.com. Thank you for listening. And if you found this information interesting, please share it with your colleagues. Stay safe, everyone.
Colon cancer is one of the most preventable cancers, and yet it is the third leading cause of cancer deaths after lung cancer, and prostate for men and breast cancer for women. In this interview, naturopathic oncologist Tina Kaczor, ND, FABNO, discusses how clinicians can help patients reduce their risk of developing colon cancer. Kaczor has been working in oncology for 2 decades and is a Fellow of the American Board of Naturopathic Oncology.
Approximate listening time: 32 minutes
About the Expert
Tina Kaczor, ND, FABNO, is editor-in-chief of Natural Medicine Journal and a naturopathic physician, board certified in naturopathic oncology. She received her naturopathic doctorate from National University of Natural Medicine, and completed her residency in naturopathic oncology at Cancer Treatment Centers of America, Tulsa, Oklahoma. Kaczor received undergraduate degrees from the State University of New York at Buffalo. She is the past president and treasurer of the Oncology Association of Naturopathic Physicians and secretary of the American Board of Naturopathic Oncology. She has been published in several peer-reviewed journals. Kaczor is based in Portland, Oregon.
There has been some misinformation circulating regarding Covid-19 and natural medicine. On this episode, critical questions regarding Covid-19 are answered by immunologist and integrative health expert Heather Zwickey, PhD. Zwickey is executive program chair and a professor at National University of Natural Medicine in Portland, OR, who also has specific training in infectious diseases.
About the Expert
Heather Zwickey, PhD, is Dean of Research and Graduate Studies and a professor of immunology at the National University of Natural Medicine, Portland, Oregon, as well as Director of Helfgott Research Institute. Currently, she heads several pilot studies looking at the effects of botanicals, hydrotherapy, energy medicine, and diet on immunological parameters. Zwickey trained at the National Jewish Medical and Research Center in Denver, Colorado. She received her doctorate in immunology and microbiology from the University of Colorado Health Sciences Center and completed a postdoctoral fellowship at Yale University.
Compelling research now shows that brain activity in the frontal cortex is a key cause of insomnia and sleeplessness. In addition, research demonstrates that temperature can play a role in calming the frontal cortex to alleviate insomnia. In this interview, listeners will learn about a new medical device that helps treat insomnia by cooling the frontal cortex. Eric Nofzinger, MD, is the creator of the first FDA-cleared wearable device for patients with insomnia. Nofzinger has more than 30 years' experience in clinical sleep disorders and sleep research.
About the Expert
Eric Nofzinger, MD, is the founder and chief medical officer of Ebb Therapeutics, a medical device company developing and commercializing medical devices in the area of insomnia treatment. He previously was a professor of psychiatry and the director of the Sleep Neuroimaging Research Program at the University of Pittsburgh, School of Medicine. He is a past-president of the Sleep Research Society and a past-president of the Sleep Research Society Foundation.
Nofzinger received his medical degree from the Ohio State University School of Medicine in Columbus, Ohio. He completed residency training in psychiatry and a postgraduate National Institute of Mental Health (NIMH) extramural research fellowship in Sleep Research at the University of Pittsburgh, School of Medicine.
Nofzinger has over 30 years' experience in clinical sleep disorders medicine and in sleep research. Most recently his work has focused on the development of novel brain-based interventions for the treatment of sleep disorders. He has presented and published extensively on the results of his sleep neuroimaging research in leading journals and textbooks, including SLEEP, the Archives of Internal Medicine, the Archives of General Psychiatry, the American Journal of Psychiatry, Sleep Medicine Reviews, and Brain.
About the Sponsor
Ebb Therapeutics aims to improve sleep through the power of cooling technology. It offers a first-of-its-kind wearable sleep device that targets a racing mind, using precise cooling to reduce metabolic activity in the frontal cortex of the brain and relieve sleeplessness. Visit Ebbsleep.com.
The research regarding intermittent fasting has grown significantly over the past five years. Why is that? In this interview, integrative medical expert Ronald Hoffman, MD, describes the health benefits and provides advice about why and how to talk to patients about this way of eating. Hoffman is recognized as one of America's foremost integrative medicine practitioners.
Here is a link to the paper by de Cabo and Mattson that Hoffman mentions in this interview: https://www.gwern.net/docs/longevity/2019-decabo.pdf.
About the Expert
Ronald Hoffman, MD, is a physician in private practice of integrative medicine in New York City. He is a graduate of Columbia College and Albert Einstein College of Medicine. Since 1984, he has served as Medical Director of the Hoffman Center in Manhattan. Hoffman is past president of the American College for the Advancement of Medicine (ACAM).
Hoffman is the host of Intelligent Medicine, a nationally syndicated radio program, and he produces the daily Intelligent Medicine podcast. He is a certified nutrition specialist (CNS) and the author of several books, including How to Talk with Your Doctor (About Complementary and Alternative Medicine).
On this episode, immunologist and researcher Heather Zwickey, PhD, discusses the present coronavirus and how infectious diseases take hold. She also talks about how patients can reduce risk of coronavirus, as well as cold and flu. Zwickey describes the practitioner’s role in helping to control disease spread and improve patient outcomes during an infectious outbreak. Zwickey is executive program chair and a professor at National University of Natural Medicine in Portland, OR.
About the Expert
Heather Zwickey, PhD, is Dean of Research and Graduate Studies and a professor of immunology at the National University of Natural Medicine, Portland, Oregon, as well as Director of Helfgott Research Institute. Currently, she heads several pilot studies looking at the effects of botanicals, hydrotherapy, energy medicine, and diet on immunological parameters. Zwickey trained at the National Jewish Medical and Research Center in Denver, Colorado. She received her doctorate in immunology and microbiology from the University of Colorado Health Sciences Center and completed a postdoctoral fellowship at Yale University.
In this interview, kidney health expert Matthew Hand, DO, describes how an integrative approach can help improve outcomes and quality of life for patients with kidney disease. Hand is the section chief for pediatric nephrology at Children's Hospital at Dartmouth. He provides practical clinical advice on how best to support patients who have kidney disease or those who are at high risk.
About the Expert
Matthew Hand, DO, is the section chief for pediatric nephrology at Children’s Hospital at Dartmouth. He graduated from Chicago College of Osteopathic Medicine in 1989 and did his pediatric residency and chief residency at Maine Medical Center. Hand then completed his fellowship in pediatric nephrology at Children’s Hospital in Boston. Subsequently, he developed the pediatric nephrology division at the Barbara Bush Children’s Hospital at Maine Medical Center. In 2008 he graduated from Andrew Weil’s fellowship in Integrative Medicine at the University of Arizona and created the pediatric integrative medicine division at Maine Medical Center. In 2011, Hand was hired by New Hampshire’s Hospital for Children at the Elliot Hospital to develop the pediatric nephrology division and to create a children’s hospital with integrative medicine as its cornerstone. He has been featured in a number of international television shows including 20/20, the Discovery Channel and the Oprah Winfrey Show.
Nicotinamide adenine dinucleotide (NAD) is a hot topic in antiaging medicine. In this interview, Christopher Shade, PhD, describes the key pathways that NAD uses to exert its health-promoting and antiaging functions in the body. He also explains how NAD levels can be increased by utilizing the salvage pathway with targeted nutrients. Shade is an expert who specializes in biological, environmental, and analytical chemistry.
About the Expert
Christopher Shade, PhD, obtained bachelor of science and masters of science degrees from Lehigh University in environmental and aqueous chemistry, and a PhD from the University of Illinois where he studied metal-ligand interactions in the environment and specialized in the analytical chemistries of mercury. During his PhD work, Shade patented analytical technology for mercury speciation analysis and later founded Quicksilver Scientific, LLC, to commercialize this technology. Shortly after starting Quicksilver Scientific, Shade turned his focus to the human aspects of mercury toxicity and the functioning of the human detoxification system. He has since researched and developed superior liposomal delivery systems for the nutraceutical and wellness markets and also specific clinical analytical techniques for measuring human mercury exposure. He used his understanding of mercury and glutathione chemistry to design a unique system of products for detoxification that repairs and then maximizes the natural detoxification system.
About the Sponsor
Quicksilver Scientific is a leading manufacturer of advanced nutritional systems with a focus on detoxification. We specialize in superior liposomal delivery systems and heavy metal testing to support optimal health. Our advanced liposomal supplements are highly absorbable, and support the body in the elimination of ubiquitous toxins, enabling you to achieve your genetic potential. At Quicksilver Scientific, we are passionate about health and well-being, and are committed to improving the lives of everyone we touch.
Learn more about Quicksilver Scientific NAD+ Gold™.
Natural Medicine Journal editorial board member and frequent contributor Kurt Beil, ND, LAc, MPH, specializes in the use of natural environments and urban green space as a key bridge to healing. In this podcast, he discusses how he utilizes the healing power of nature with his patients. Beil describes the most recent green space research and gives healthcare professionals advice on how they can incorporate this healing tool into clinical practice.
About the Expert
Kurt Beil, ND, LAc, MPH, is a naturopathic and Chinese medicine practitioner in Sandy, Oregon with an ongoing commuter practice to his native Hudson Valley in New York state. He is a Research Investigator at NUNM’s Helfgott Research Institute, where he completed his post-doctoral research project on biomarker and psychometric assessment of the restorative and therapeutic effect of natural vs. built urban environments. Beil holds a Master’s degree in public health focused on the benefits of green space as a sustainable public health promotion tool, and speaks and writes regularly about these topics. He has taught courses on these topics at NUNM and the Academy of Integrative Health & Medicine, has been an advisor to the Children & Nature Network’s “Nature Research Database” and was the founding co-chair of the Nature & Health subcommittee of the Intertwine Alliance in Portland. He is currently an editor and regular contributor to the Natural Medicine Journal, and writes a weekly blog on the topics of Nature & Health. Beil also maintains a Facebook group (“Naturopaths for Nature”) for the naturopathic medicine community on the clinical health benefits of contact with nature. He can be reached at drkurt@earthlink.net or www.drkurtbeil.com.
In this interview, Robert MacCuspie, PhD, discusses the safety and efficacy of bioactive silver hydrosol, a special form of colloidal silver. MacCuspie also describes the various clinical applications, dosages, and how to best use this product in clinical practice.
Continuing Education Credits Available
This podcast interview qualifies for 0.5 general continuing education (CE) units. The Oregon Board of Naturopathic Medicine has approved this educational content for 0.5 “general” CE units for naturopathic physicians. Naturopathic physicians licensed in any U.S. state except California may obtain general CE by listening to this podcast and completing a 10-question test on the material contained within the clinical topic. Click the button below to take the test for FREE, thanks to an educational grant from Natural Immunogenics Corp. Upon successful completion, you will receive an email confirming you passed. This CE approval may also qualify for the CE requirements of other practitioner types.
About the Expert
Robert MacCuspie, PhD, is the director of science for Natural Immunogenics Corporation. He holds a PhD in nanotechnology and materials chemistry and has 20 years of experience in nanotechnology, including over 12 years specifically in silver nanotechnology. MacCuspie has worked for several US national labs, including the US Food and Drug Administration, the Air Force Research Laboratory, and the National Institute of Standards and Technology, where he developed their silver nanoparticle reference materials and was an international leader in nanomaterial environmental health and safety research. MacCuspie was the first faculty and director of Nanotechnology & Multifunctional Materials programs at Florida Polytechnic University and served on their board of trustees. MacCuspie holds 1 US patent and has written 2 book chapters and 42 peer-reviewed manuscripts, which have been cited more than 2,900 times with an h-index of 29.
About the Sponsor
Natural Immunogenics Corporation (NIC), the leader in Hydrosol Technology, is a family-owned business in Sarasota Florida, established in 1998. With its commitment to the principles of Health Freedom and Health Sovereignty, NIC is a market leader of silver based dietary supplements and topical products, and is the manufacturer of Sovereign Silver and Argentyn 23 Bio-Active Silver Hydrosol and Homeopathic First Aid Gel. The company’s retail brand Sovereign Silver has 64% market share in the natural products retail space, and Argentyn 23 is sold exclusively through licensed practitioners in thousands of clinics around the globe.
In this interview, Anne McTiernan, MD, PhD, discusses the ongoing program with the American Institute for Cancer Research (AICR) that analyses research associated with diet and lifestyle efforts to reduce cancer risk. Known as the Continuous Update Project (CUP), findings from this effort are used to form AICR's expert cancer prevention recommendations. McTiernan will also discuss her present research at the Fred Hutchinson Cancer Research Center in Washington.
About the Expert
Anne McTiernan, MD, PhD, is a full member at the Fred Hutchinson Cancer Research Center, Seattle, and research professor at the University of Washington Schools of Medicine and Public Health. Her research focuses on exercise, diet, obesity, and risk for cancer development and prognosis. She served on the U.S. Physical Activity Guidelines Advisory Committees and the AICR/World Cancer Research Fund expert panels. She has published more than 400 scientific manuscripts and is lead author of the book Breast Fitness (St. Martin’s Press). McTiernan’s memoir is Starved: A Nutrition Doctor’s Journey from Empty to Full (Central Recovery Press). For more information about the AICR, visit aicr.org. For more information about McTiernan, visit annemctiernan.com.
Innovation is vital to the development and execution of new practices, techniques, and tools in healthcare. But with that innovation, ethical issues can arise. In this interview, seasoned healthcare expert and educator Howard Gershon describes some of the key concerns associated with innovation and medicine.
About the Expert
Howard Gershon is a principal with the New Heights Group, an independent management consulting firm to the healthcare industry. He has also been a faculty member with the American College of Healthcare Executives for more than 18 years. Howard holds a BA in Business/Managerial Economics from Alfred University and he earned his Masters in Health Care Administration from The George Washington University.
In the United States cases of autism and attention deficit hyperactivity disorder (ADHD) continue to rise. In this podcast, pediatric expert Matthew Hand, DO, describes why an integrative approach makes sense. Hand, who is the section chief for pediatric nephrology at Children's Hospital at Dartmouth, discusses his focus on diet, lifestyle, and dietary supplements to treat these 2 conditions.
About the Expert
Matthew Hand, DO, is the section chief for pediatric nephrology at Children’s Hospital at Dartmouth. He graduated from Chicago College of Osteopathic Medicine in 1989 and did his pediatric residency and chief residency at Maine Medical Center. Hand then completed his fellowship in pediatric nephrology at Children’s Hospital in Boston. Subsequently, he developed the pediatric nephrology division at the Barbara Bush Children’s Hospital at Maine Medical Center. In 2008 he graduated from Andrew Weil’s fellowship in Integrative Medicine at the University of Arizona and created the pediatric integrative medicine division at Maine Medical Center. In 2011, Hand was hired by New Hampshire’s Hospital for Children at the Elliot Hospital to develop the pediatric nephrology division and to create a children’s hospital with integrative medicine as its cornerstone. He has been featured in a number of international television shows including 20/20, the Discovery Channel and the Oprah Winfrey Show.
About the Sponsor
DaVinci Labs believes that better health starts with better information. We have compiled an array of educational media aimed at providing the most cutting-edge education and practice support for today’s integrative practitioner, as well as providing everything an inquisitive consumer needs to know to take control of their own health: